Table 4.
Bioactive | Polymers | Routes of Administration | Reference |
---|---|---|---|
VEGF inhibitors | PNIPAAm | Intravitreal (injection) | [40] |
Fluocinolone acetonide | Polyimide | Intravitreal (implant) | [86] |
Fuconazole | Gellan gum, carragenan | Topical | [87] |
Bevacizumab | Poly (ethylene glycol)-poly (ε-caprolactone)-poly (ethylene glycol) | Intracameral | [88] |